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INTRODUCTION
Approximately 80% of the patients admitted into inten-
sive care units survive the acute event, and most remain in
this unit briefly.1 However, a subgroup does not recover
sufficiently quickly to become independent and from then
they recover slowly.2 These patients are called chronically
critically ill (CCI) patients, and, depending on the definition
criteria, comprise 5 to 10% of the patients admitted into
intensive care units.3-5
There is a great deal of controversy regarding the
definition of a CCI patient. The two most commonly used
definitions are the duration of mechanical ventilation (MV)
and tracheostomy.2 The advantage of the latter is that the
patients are identified by a code, simplifying the extraction
of information from a secondary database.2 However, the
great variability in the indication of tracheostomy and its
tendency to be performed increasingly early may contribute
to the selection of patients with different evolutions than
those of chronic patients.6,7 MV varies from 4 to 29 days
across different studies.2 A recent consensus conference
defined patients with cases of prolonged MV as those who
need invasive MV for at least 21 days.8
Regardless of the definition, the main characteristics of this
population are repeated episodes of shock and infection during
their stays in the Intensive Care Unit (ICU).9 It is clear that a
chronic critical illness is not simply an extension of an acute
critical illness but, rather, is a complex syndrome characterized
by metabolic, neuroendocrine, neuropsychiatric and immuno-
logical changes.10
This study aims to compare the two definitions of CCI
patients: tracheostomy (Tracheo group) and MV $ 21 days
(MV group). In addition, we described the clinical,
epidemiological and outcome characteristics of the CCI
patients and tried to identify the factors that predispose
patients to the evolution to chronic critical illness.
METHODS
This prospective observational study was developed in a
single ICU with 25 medical-surgical beds at a university
hospital in Porto Alegre, Brazil. All of the patients who were
admitted into the ICU between February and May 2007
were included in the study. Any patient who stayed in the
Intensive Care Unit for less than 24 hours and those who
already had a tracheostomy upon admission were excluded.
The study was approved by the Institutional Ethics
Committee. Informed consent was waived because no
interventions were performed on the patients.
We used two definitions of CCI: tracheostomy performed
for continued MV and a duration of mechanical ventilation
lasting $ 21 days. During the period of study, a tracheost-
omy was performed only when the attending team deemed
it necessary to wean the patient from mechanical ventila-
tion. There were no tracheostomy cases for any other reason.
The following variables were collected at upon admission:
age; gender; the main diagnosis in the ICU; where they were
before admission to the ICU and the length of stay there; the
type of admission; any preexisting illnesses ranked by a
McCabe score (either as non-fatal [score of 1], ultimately
fatal [score of 2] or rapidly fatal [score of 3]);11 the presence
of ARDS (Acute Respiratory Distress Syndrome);12 the
presence of shock;13 sepsis; the severity of the disease
(according to APACHE II [Acute Physiology and Chronic
Health Evaluation] score) 14 and organ dysfunction (defined
as a SOFA score . 2 points in the organ systems that were
evaluated, which included the cardiovascular, respiratory,
neurological, hematological, renal and hepatic systems).15
The daily incidence of ARDS, shock, infection, organ
dysfunction, and tracheostomy and the length of time on
MV was recorded prospectively. The evaluation outcomes
were the evolution to chronic critical illness and the
mortality in the ICU or in the hospital.
The results are presented as percentages ¡ standard
deviation. The groups were compared using the x-square test
or Fisher’s exact test to compare percentages or Student’s t test
or the Kruskal-Wallis test to analyze the continuous variables.
A multivariate analysis was performed to determine the risk
factors for evolution to chronic critical illness using backward
stepwise multiple logistic regression. Factors with a value of p
, 0.1 (as determined by a univariate analysis) were selected
for the model. A value of p, 0.05 was considered to be
statistically significant. No statistical analysis was performed
when comparing the two definitions of CCI due to the overlap
between the two groups.
RESULTS
During the study period, 274 patients were admitted into
the ICU. Twenty-two of these patients were excluded
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because they stayed in the ICU for less than 24 hours, which
left 252 patients for the final analysis. Twenty-four (9.5%)
patients were considered to be CCI according to one of the
two possible definitions. Nineteen patients (7.5%) met the
tracheostomy criterion. Fifteen (6.0%) patients had MV for at
least 21 days. Ten (66.7%) of these were tracheostomized
and, therefore, fulfilled both definitions.
The characteristics of non-chronic patients the tracheo
group and the MV group are shown in Table 1.
When the two CCI patient definitions were compared, the
patients in theMVGroupweremore severe, with more organ
dysfunction and higher mortality in the ICU and in the
hospital. (A statistical comparison was not performed due to
the overlap between the two groups.) When comparing this
group of patients to the non-chronic population, a significant
difference in both ICU and hospital mortality was observed.
The evolution of the CCI patients was characterized by
repeated episodes of infection and shock, a higher
incidence of ARDS and a longer duration of MV and
length of stay in the ICU and in the hospital.
The median time until a tracheostomy was performed
was 13.0 days of MV. Nine (37.5%) patients received MV for
Table 1 - Clinical characteristics and outcome variables of CCI patients defined by either tracheostomy or MV for $ 21
days compared to the remainder of the patients in the ICU.
Variable Tracheo group MV group Non-CCI
N 19 15 228
Age 59.3 ¡ 17.9 63.9 ¡ 12.9 54.4 ¡ 18.6b
Gender, male n (%) 9 (47.4) 6 (40.0) 121 (53.1)
Place before admission
Ward 9 (47.4) 8 (53.3) 57 (25.0)a,b
Emergency 3 (15.8) 2 (13.3) 61 (26.8)
Another hospital 3 (15.8) 3 (20.0) 21 (9.2)
Operating room 4 (21.0) 2 (13.3) 84 (36.8)
Another place - - 5 (2.2)
Length of stay in the previous location 8.9 ¡ 13.2 7.7 ¡ 8.9 7.5 ¡ 11.2
McCabe score
1 16 (84.2) 13 (86.7) 193 (84.6)
2 3 (15.8) 2 (13.3) 32 (14.0)
3 - - 3 (1.3)
Type of admission
Medical 15 (78.9) 13 (86.7) 141 (61.8)
Elective surgery 3 (15.8) 1 (6.7) 62 (27.2)
Emergency surgery 1 (5.3) 1 (6.7) 25 (11.0)
Reason for ICU admission n(%)
Sepsis 1 (5.3) 2 (13.3) 54 (23.7)
Cardiovascular 3 (15.9) 2 (13.3) 12 (5.3)
Respiratory 6 (31.6) 7 (46.7) 33 (14.5)
Neurological 5 (26,3) 1 (6.7) 29 (12.7)
Gastrointestinal - - 7 (3.1)
Postoperative 4 (21.0) 2 (13.3) 84 (36.8)
Miscellaneous - 1 (6.7) 9 (3.9)
ARDS
Upon admission 2 (10.5) 2 (13.3) 6 (2.6)
During evolution 4 (21.1) 5 (33.3) 15 (6.6)a,b
Shock
Upon admission 3 (15.8) 3 (20.0) 66 (28.9)
During evolution 15 (78.9) 15 (100.0) 96 (42.1)a,b
Number of shock episodes 1.1 ¡ 0.7 1.5 ¡ 0.6 0.5 ¡ 0.8a,b
Sepsis upon admission 10 (52.6) 11 (73.3) 98 (43.0)b
Number of infection episodes 2.7 ¡ 2.1 3.1 ¡ 2.2 0.8 ¡ 0.8a,b
APACHE II 24.0 ¡ 8.4 26.1 ¡ 8.1 19.7 ¡ 8.0a,b
SOFA 6.4 ¡ 2.9 6.9 ¡ 3.8 5.7 ¡ 3.7
SOFA – neurological 1.6 ¡ 1.6 1.1 ¡ 1.6 0.7 ¡ 1.2a
SOFA – cardiovascular 0.8 ¡ 1.5 1.1 ¡ 1.7 1.0 ¡ 1.5
SOFA – respiratory 2.8 ¡ 0.7 3.0 ¡ 0.5 2.0 ¡ 1.2a,b
SOFA – renal 0.7 ¡ 1.2 0.9 ¡ 1.2 1.0 ¡ 1.4
SOFA – hematological 0.3 ¡ 0.8 0.6 ¡ 1.1 0.5 ¡ 0.9
SOFA – hepatic 0.2 ¡ 0.7 0.3 ¡ 0.9 0.5 ¡ 0.9
Dialysis (in evolution) 5 (26.3) 7 (46.7) 44 (19.3)b
MV (in evolution) 19 (100.0) 15 (100.0) 149 (65.4)a,b
Days on MV 32.2 ¡ 25.2 40.7 ¡ 24.3 3.4 ¡ 4.6a,b
Days in the ICU 36.2 ¡ 25.3 44.6 ¡ 24.4 6.2 ¡ 5.4a,b
Days in the hospital 68.4 ¡ 42.2 68.9 ¡ 44.6 26.3 ¡ 18.3a,b
ICU mortality 4 (21.1) 7 (46.7) 57 (25.0)b
Hospital mortality 10 (52.6) 9 (60.0) 78 (34.2)b
a, p , 0.05 for comparisons between the Tracheo group and the non-CCI patients.
b, p , 0.05 for comparisons between MV group and the non-CCI patients.
CCI, chronically critically ill; MV, mechanical ventilation; ICU, intensive care unit; ARDS, acute respiratory distress syndrome; APACHE, Acute Physiology
and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.
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more than 30 days, and 2 (8.3%) patients received MV for
more than 80 days.
Although they were only 9.5% of the total population, the
CCI patients accounted for 846 ICU bed-days, which
represented 37.4% of the total number of ICU bed-days
during the study period.
The admission factors that were associated with the
evolution to chronic critical illness (as assessed by the
univariate analysis) were neurological dysfunction, admis-
sion from a ward, pulmonary dysfunction and a higher
APACHE II score (Table 2). Due to the small number of CCI
patients, the multivariate analysis could not identify a
variable that was independently associated with the evolu-
tion to chronic critical illness.
Only the patient age was different between surviving and
non-surviving CCI patients (Table 3). All of the patients in
this group who were more than 75 years old died in the
hospital.
DISCUSSION
The main contribution of our study is the finding that the
CCI patients who were defined by a duration of MV of $ 21
days were more severely ill than those defined by
tracheostomy. The first definition appears to be more
specific and manages to include a subgroup that is distinct
from the rest of the critically ill population.
We found that MV group had higher APACHE II and
SOFA scores, higher rates of infection and shock, a greater
need for dialysis and increased mortality in the ICU and in
the hospital. Another recent study reported that those who
are chronically ill according to a duration of MV of $ 21
days had higher mortality and used more resources than
those who were chronic due to tracheostomy.6
It may be important to identify patients with a high risk of
becoming chronic early to be able to manage them. In our
study, a higher APACHE II score, neurological dysfunction,
pulmonary dysfunction and admission from a ward were
associated with the evolution to chronic critical illness.
The severity scores have been identified as predictors of
prolonged MV,3,9 although with low accuracy.16,17
Admission from a ward has been previously identified as
a factor associated with the evolution to chronic critical
illness.3 The status of neurological dysfunction as a
predictor of CCI is a new finding. Presumably, this result
is due to the very early tracheostomy in neurological
patients,18 who do not necessarily depend on MV.
Although CCI patients are in worse condition when they
are admitted into the ICU, the impact of a prolonged stay in
the ICU on the survival of these patients is still controver-
sial. It is very difficult to compare these studies because they
are heterogeneous. Some have found higher mortality in
CCI patients,5,19,20 while others have not.6,9 The mortality
found in our study varied according to the definition used;
the CCI patients on MV for$ 21 days had a higher mortality
than the rest of the population, and this difference was not
found when tracheostomy was the criterion.
Indeed, some patients may benefit from these efforts, and
others may not.21 In this scenario, identifying the predictors
of a poor prognosis might help doctors choose more
aggressive treatments or treatments that prioritize comfort.21
In our study, only patient age was associated with mortality
in the CCI patients. The subgroup that was 75 years or older
had 100%mortality. Indeed, age appears to be a major factor,
as this group was not different from the remainder of the
chronic patients in terms of their severity or comorbidity
scores. Recently, the ProVent score (a need for a vasopressor,
hemodialysis, a platelet count of #1506109/L and age $ 50
years) was created to predict mortality in this group and had
good discriminatory power.22
This study has a few limitations. First, because it was
performed in a single ICU, it is difficult to generalize the
results. Second, the small number of patients may limit the
analysis of the results, thus limiting its generalization even
further. Finally, its observational design may have added
selection bias, as there is great variability in the indication
for a tracheostomy. However, comparing these two defini-
tions of CCI patients will help identify this difference.
CONCLUSIONS
CCI patients are in a more severe condition upon
admission into the ICU, and their evolution is characterized
by repeated episodes of infection and shock. Defining CCI
patients according to their MV time ($ 21 days) appears to
be more specific and includes a subgroup that is markedly
different from the remainder of the critically ill population.
This should be taken into account in future studies.
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